Integration of Hypertension Management into HIV Care in Nigeria: A Task Strengthening Strategy

尼日利亚将高血压管理纳入艾滋病毒护理:任务强化策略

基本信息

项目摘要

Abstract The “Integration of Hypertension Management into HIV Care in Nigeria: A Task Strengthening Strategy” (TASSH NIMR) parent study is an ongoing clinical effectiveness implementation trial that evaluates the effectiveness of an implementation strategy to integrate a task-strengthening strategy for hypertension control (TASSH) in HIV clinics in Lagos State (R01HL147811). In response to NOT-OD-21-020, we propose this administrative supplement, “Establishing an Ethics Learning Collaborative for HIV-Hypertension Integration through a TAsk Strengthening Strategy for Hypertension Control in Lagos State, Nigeria” (E-LinC TASSH). E-LinC TASSH will leverage the TASSH NIMR Steering Committee to form an Ethics Learning Collaborative (ELC), which will identify, analyze, and characterize ethical considerations for implementing a practice facilitation–guided task- strengthening approach to couple hypertension and HIV treatment within primary health care centers throughout Lagos State. Additionally, E-LinC TASSH will develop an ethics-informed strategy for scaling up, spreading, and sustaining the TASSH NIMR intervention in HIV clinics throughout Lagos State. To better appreciate an implementation research informed learning collaboratives to advance bioethical considerations in HIV- hypertension integration, this supplement will also evaluate use of an ethics focused learning collaborative. Expansion into this area of bioethics research will allow us to comprehensively understand and contextualize ethical considerations of implementing this treatment and management model. This bioethics research will enable us to develop strategies for managing and solving ethical challenges arising in our implementation research and scale-up of the TASSH NIMR strategy. TASSH NIMR is currently in the pre-implementation or planning phase and will begin recruitment in time for the proposed research to enhance the intervention's impact and to inform the next steps for scaling up, spreading, and sustaining the intervention within the Lagos State primary healthcare network. In addition to engaging in the proposed bioethics research, E-LinC TASSH will build research ethics and bioethics capacity among ELC members through expert-facilitated discussions and activities involved in developing the survey, engaging stakeholders, interpreting findings, and integrating this new knowledge into practical strategies. Per instructions in NOT-OD-21-020, this supplement is specific to bioethics research and capacity building.
抽象的 “将高血压管理整合到尼日利亚的艾滋病毒护理中:一项任务加强策略”(tassh NIMR)父母研究是一项持续的临床实施试验,可评估 艾滋病毒中高血压控制(TASSH)的任务加密策略(TASSH)的实施策略 拉各斯州的诊所(R01HL147811)。为了响应Not-OD-21-020,我们提出了此管理 补充,“通过一项任务建立伦理学学习合作型艾滋病毒 - 亚型融合 加强尼日利亚拉各斯州高血压控制的策略”(e-linc tassh)。 利用Tassh NIMR指导委员会组成道德学习协作(ELC),该委员会将 识别,分析和表征实施实践设施的任务的道德考虑因素 - 加强在整个初级卫生保健中心内的高血压和艾滋病毒治疗的方法 拉各斯州。 Exther,e-linc tassh将制定一种知名的伦理策略来扩展,传播和 维持整个拉各斯州HIV诊所的TASSH NIMR干预。更好地欣赏 实施研究告知学习协作,以促进艾滋病毒的生物伦理考虑因素 高血压整合,该补充剂还将评估以道德为中心的学习协作的使用。 扩展到这一生物伦理学研究领域将使我们能够全面理解和背景化 实施这种治疗和管理模型的道德考虑。这项生物伦理学研究将 使我们能够制定管理和解决在实施中引起的道德挑战的策略 TASSH NIMR策略的研究和扩展。 Tassh Nimr目前正在实施前或 计划阶段,并将开始及时招募拟议的研究以增强干预的影响 并告知下一步以扩大,扩展和维持拉各斯州内的干预措施 初级医疗网络。除了从事拟议的生物伦理学研究外,E-Linc Tassh还将建立 ELC成员通过专家的讨论和活动研究伦理和生物伦理学能力 参与制定调查,吸引利益相关者,解释发现并整合这一新的调查 知识进入实际策略。 根据NOT-OD-21-020中的说明,该补充是生物伦理学研究和能力建设的特定的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OLIVER CHUKWUJEKWU EZECHI其他文献

OLIVER CHUKWUJEKWU EZECHI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OLIVER CHUKWUJEKWU EZECHI', 18)}}的其他基金

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST)
维持创新工具以扩大青少年友好型艾滋病毒自我检测 (S-ITEST)
  • 批准号:
    10933892
  • 财政年份:
    2024
  • 资助金额:
    $ 13.59万
  • 项目类别:
Innovative Tools to Expand Music-Inspired Strategies for Blood Pressure and Stroke Prevention (I-TEST BP/Stroke)
扩展受音乐启发的血压和中风预防策略的创新工具(I-TEST BP/中风)
  • 批准号:
    10937709
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
US-Nigerian Cancer Control Center for Research on Implementation Science and Equity (C3-RISE)
美国-尼日利亚癌症控制实施科学与公平研究中心 (C3-RISE)
  • 批准号:
    10738439
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Actions for Collaborative Community Engaged Strategies for HPV (ACCESS HPV)
HPV 社区参与协作策略行动 (ACCESS HPV)
  • 批准号:
    10708926
  • 财政年份:
    2022
  • 资助金额:
    $ 13.59万
  • 项目类别:
Actions for Collaborative Community Engaged Strategies for HPV (ACCESS HPV)
HPV 社区参与协作策略行动 (ACCESS HPV)
  • 批准号:
    10587502
  • 财政年份:
    2022
  • 资助金额:
    $ 13.59万
  • 项目类别:
Predictors of Antiretroviral Immunereconstitution Bone Loss - the Gut and the Microbiome
抗逆转录病毒免疫重建骨丢失的预测因素 - 肠道和微生物组
  • 批准号:
    10491843
  • 财政年份:
    2021
  • 资助金额:
    $ 13.59万
  • 项目类别:
Predictors of Antiretroviral Immunereconstitution Bone Loss - the Gut and the Microbiome
抗逆转录病毒免疫重建骨丢失的预测因素 - 肠道和微生物组
  • 批准号:
    10701767
  • 财政年份:
    2021
  • 资助金额:
    $ 13.59万
  • 项目类别:
Predictors of Antiretroviral Immunereconstitution Bone Loss - the Gut and the Microbiome
抗逆转录病毒免疫重建骨丢失的预测因素 - 肠道和微生物组
  • 批准号:
    10326900
  • 财政年份:
    2021
  • 资助金额:
    $ 13.59万
  • 项目类别:
Integration of Hypertension Management into HIV Care in Nigeria: A Task Strengthening Strategy
尼日利亚将高血压管理纳入艾滋病毒护理:任务强化策略
  • 批准号:
    10337310
  • 财政年份:
    2020
  • 资助金额:
    $ 13.59万
  • 项目类别:
Integration of Hypertension Management into HIV Care in Nigeria: A Task Strengthening Strategy
尼日利亚将高血压管理纳入艾滋病毒护理:任务强化策略
  • 批准号:
    9926582
  • 财政年份:
    2020
  • 资助金额:
    $ 13.59万
  • 项目类别:

相似海外基金

The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - EIS
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
  • 批准号:
    10686546
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
I-TRANSFER Improving TRansitions ANd outcomeS oF sEpsis suRvivors
I-TRANSFER 改善脓毒症幸存者的转变和结果
  • 批准号:
    10824878
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Evaluation and optimization of NWB neurophysiology software and data in the cloud
NWB 神经生理学软件和云数据的评估和优化
  • 批准号:
    10827688
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Developing a pragmatic guide to implementing social risk referrals: A partnership between Caring Health Center (CHC) and the Implementation Science Center for Cancer
制定实施社会风险转诊的实用指南:关爱健康中心 (CHC) 与癌症实施科学中心之间的合作伙伴关系
  • 批准号:
    10822141
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了